DNA Methyltransferase Inhibitors: Development and Applications

Area of Science:

• Epigenetics
• Molecular Biology
• Pharmacology

Background:

• DNA methylation is a crucial epigenetic mechanism regulating gene expression.
• DNA methyltransferases (DNMTs) control DNA methylation patterns.
• Modulating DNMT activity is a key strategy for altering DNA methylation levels.

Purpose of the Study:

• To review examples and applications of DNMT inhibitors (DNMTi).
• To explore DNMTi as therapeutic agents in diseases like cancer, cardiovascular, and neurological disorders.
• To discuss DNMTi as bioengineering tools and future perspectives.

Main Methods:

• Literature review of DNMT inhibitors and their applications.
• Analysis of therapeutic potential in various disease models.
• Discussion of current limitations and future research directions.

Main Results:

• DNMT inhibitors show promise as therapeutic molecules for cancers, cardiovascular, and neurological diseases.
• DNMTi can also serve as valuable tools in bioengineering.
• Current DNMT inhibitors have limitations that necessitate further development.

Conclusions:

• DNMT inhibitors represent a significant therapeutic strategy for epigenetic modulation.
• Further research is needed to overcome existing limitations and develop improved DNMTi.
• The development of novel DNMTi holds promise for treating a range of diseases and advancing bioengineering applications.